Title : Androgen decline and survival during docetaxel therapy in metastatic castration resistant prostate cancer (mCRPC).

Pub. Date : 2020 Mar

PMID : 31053766






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Docetaxel impairs microtubules, has androgen receptor (AR) inhibitory effects and is used in both the castration resistant and sensitive settings, where androgen dynamics may impact outcome. Docetaxel androgen receptor Homo sapiens
2 Docetaxel impairs microtubules, has androgen receptor (AR) inhibitory effects and is used in both the castration resistant and sensitive settings, where androgen dynamics may impact outcome. Docetaxel androgen receptor Homo sapiens